$1.32
-0.08-5.71%
At close: -
$1.32
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Outlook Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:OTLK | Benzinga
Outlook Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS Estimate
$-0.340
Quarterly Revenue Estimate
$702.60K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Outlook Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics | -$1.55 | -$0.34 | — | — | $0.00 | $702.60K | — | — | 05/14/2025 | Get Alert |
| OTLK | Outlook Therapeutics | -$0.80 | -$0.52 | -$0.89 | -71.15% | $0.00 | — | $0.00 | — | 02/14/2025 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.00 | -$0.85 | -$0.94 | -10.59% | $0.00 | — | $0.00 | — | 12/27/2024 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.38 | -$1.01 | -$0.83 | 17.82% | $0.00 | — | $0.00 | — | 08/14/2024 | Get Alert |
| OTLK | Outlook Therapeutics | -$0.52 | -$0.85 | -$1.55 | -82.35% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.60 | — | -$0.80 | — | $0.00 | — | $0.00 | — | 02/14/2024 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.20 | — | -$1.00 | — | $0.00 | — | $0.00 | — | 12/22/2023 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.60 | -$1.00 | -$1.60 | -60.00% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.80 | -$1.20 | -$0.60 | 50.00% | $0.00 | — | $0.00 | — | 05/15/2023 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.40 | -$0.80 | -$1.60 | -100.00% | $0.00 | — | $0.00 | — | 02/14/2023 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.60 | -$1.40 | -$1.20 | 14.29% | $0.00 | — | $0.00 | — | 12/29/2022 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.40 | — | -$1.60 | — | $0.00 | — | $0.00 | — | 08/10/2022 | Get Alert |
| OTLK | Outlook Therapeutics | -$1.80 | — | -$1.80 | — | $0.00 | — | $0.00 | — | 05/13/2022 | Get Alert |
| OTLK | Outlook Therapeutics | -$2.40 | -$1.20 | -$1.40 | -16.67% | $0.00 | — | $0.00 | — | 02/14/2022 | Get Alert |
| OTLK | Outlook Therapeutics | -$0.60 | -$1.20 | -$1.60 | -33.33% | $0.00 | $300.00K | $0.00 | -100.00% | 12/22/2021 | Get Alert |
| OTLK | Outlook Therapeutics | -$0.60 | -$1.40 | -$1.40 | 0.00% | $0.00 | $320.00K | $0.00 | -100.00% | 08/13/2021 | Get Alert |
| OTLK | Outlook Therapeutics | -$2.60 | -$1.80 | -$1.80 | 0.00% | $0.00 | $320.00K | $0.00 | -100.00% | 05/14/2021 | Get Alert |
| OTLK | Outlook Therapeutics | -$12.40 | — | -$2.40 | — | $0.00 | — | $0.00 | — | 02/16/2021 | Get Alert |
| OTLK | Outlook Therapeutics | -$39.60 | — | -$0.60 | — | $5.85M | — | $0.00 | — | 12/23/2020 | Get Alert |
| OTLK | Outlook Therapeutics | -$4.80 | — | -$2.20 | — | $584.00K | — | $0.00 | — | 08/14/2020 | Get Alert |
| OTLK | Outlook Therapeutics | -$11.60 | — | -$2.60 | — | $641.00K | — | $0.00 | — | 05/15/2020 | Get Alert |
Outlook Therapeutics (OTLK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-02-14 | $-0.89 | $-0.52 | -71.2 % |
| Q4 | 2024-12-27 | $-0.94 | $-0.85 | -10.6 % |
| Q3 | 2024-08-14 | $-0.83 | $-1.01 | 17.8 % |
| Q2 | 2024-05-15 | $-1.55 | $-0.85 | -82.3 % |
Outlook Therapeutics (OTLK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2021-12-22 | $0 | $300.00K | -100.0 % |
| Q3 | 2021-08-13 | $0 | $320.00K | -100.0 % |
| Q2 | 2021-05-14 | $0 | $320.00K | -100.0 % |
FAQ
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics (OTLK) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on February 14, 2025 for Q1.
What were the latest earnings per share (EPS) for Outlook Therapeutics (NASDAQ:OTLK)?
The Actual EPS was $-0.89, which missed the estimate of $-0.52.
What were Outlook Therapeutics’s (NASDAQ:OTLK) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.